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Abstract 
Reduced citrate in urine and increased fasting excre-
tion of calcium are abnormalities frequently reported in 
stone forming (SF) patients. Increased dietary acid (or 
reduced alkali) introduction or absorption may be a po-
tential cause of both these pathological findings. To test 
this hypothesis, we studied 64 SF patients {32 with fast-
ing hypercalciuria (FH) and 32 without FH (NFH)}. 
After a basal evaluation for nephrolithiasis, while on a 
500 mg calcium diet, they were evaluated for: (l) daily 
intestinal alkali absorption (IAA), by urinary electrolyte 
excretion; (2) basal concentrations of PTH, calcitonin 
(CT) and l,25(OH)2-VitD; (3) oral calcium load for 
evaluation of changes in calcium and hydroxyproline uri-
nary excretions; (4) intestinal calcium absorption (18 
patients), with double curve analysis (stable Sr as trac-
er); and (S) changes in citrate excretion after an alkali 
load (50 mEq of a mixture of calcium gluconate, lactate 
and carbonate) in 10 patients. 
The results demonstrated: (1) FH stone formers had 
reduced citrate excretion and lower mean IAA levels 
than NFH stone formers; (2) FH stone formers also had 
higher bone resorption levels with lower PTH and higher 
CT levels; (3) IAA levels were related to both citrate ex-
cretion and bone turnover indices; and (4) the increases 
in citrate excretion after oral alkali load were strictly 
related to basal IAA values (index of alkali absorption 
and/or generation after oral load), demonstrating that a 
different absorptive capacity of alkali rather than a 
different dietary content may underlie these metabolic 
abnormalities. 
Key Words: Intestinal alkali absorption, citrate, bone 
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Introduction 
Reduced urinary citrate excretion is a common trait 
among patients who form stones [9, 21, 22]. Acidosis 
is the main factor in causing hypocitraturia encountered 
in distal renal tubular acidosis [16], chronic diarrheal 
states [19], and thiazide-induced hypokalemia [20]. 
However, in most hypocitraturic stone formers (SF), no 
exact cause can be identified. Increased dietary intake 
of protein, mainly composed of sulphur-containing 
amino acids, resulting in acid load, has been suggested 
as a putative factor in "idiopathic" hypocitraturia [3]. 
Another possible explanation is that low alkali intake or 
absorption might be the causative factor. In 1987, 
Cowley et al. [6] found a reduced citraturic response af-
ter an oral citrate load in SF. Since Oh [ 17] introduced 
a simple and reliable method for the calculation of net 
gastrointestinal alkali absorption (IAA), it has been pos-
sible to directly relate citrate excretion with IAA. In-
deed, Pak [18] demonstrated that IAA, after an oral cit-
rate load, was reduced in some SF, suggesting reduced 
intestinal absorption. The first aim of the present study 
was to confirm or otherwise test this hypothesis, by di-
rectly measuring citrate excretion after an oral alkali 
load other than citrate. 
It has also been suggested that increased levels of 
bone turnover (BT), independen't of PTH secretion, 
might play a causative role in fasting hypercalciuria 
(FH) of SF [2, 13, 14], especially in conditions of rela-
tively low calcium intake [12]. In this pathophysiologic 
set, a relative hypoparathyroidismhas also been reported 
[8]. Notwithstanding a well known role of calcitonin 
(CT) in controlling BT rate [7], after the initial finding 
by Ivey et al. [10] of increased CT levels in hypercalci-
uria, little attention has as yet been paid to this hormone 
in FH SF. The second aim of our study has been to fur-
ther investigate the CT role, if any, in FH of SF. 
Furthermore, it has also been demonstrated that in-
creased dietary acid load is able to induce increased cal-
cium excretion in urine together with increased bone re-
sorption [l, 11]. The final aim of the present investiga-
tion was to assess whether the alkali composition of the 
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Table 1. Main clinical data of the two groups of patients (mean ± standard deviation, sd; ns = not significant). 
N CrCl Age 
(ml/min) (years) 
NFH 32 106 ± 4.0 39.9 ± 10.7 
FH 32 104 ± 3.8 44.3 ± 12.7 
p ns ns 
Table 2. Daily urine parameters and calculated IAA 






u-Ca mmol/day 4.6 ± 1.8 5.95 ± 2.73 < 0.05 
uNa mmol/day 140 ± 68 170 ± 89 ns 
uMg mmol/day 4.0 ± 1.5 4.5 ± 2.1 ns 
u-Pi mmol/day 26.1 ± 11.3 25.7 ± 11.9 ns 
u-Ox mmol/day 360 ± 155 398 ± 202 ns 
u-Cit mmol/day 3.68 ± 1.85 2.28 ± 1.37 < 0.05 
uUA mmol/day 4.0 ± 4.9 3.7 ± 1.4 IB 
uSulf mmol/day 21.1 ± 6.9 21.3 ± 6.7 IB 
uUrea mmol/day 328 ± 143 379 ± 136 ns 
IAA mEq/day 31.2 ± 19.4 15.3 ± 18.3 < 0.05 
diet might also play a role in increased bone turnover of 
FH. 
Patients and Methods 
Among the patients evaluated for active urolithiasis 
in our Nephrology Unit in the last 4 years, we enrolled 
64 patients (29 females, 35 males; ages 19-63 years), on 
the basis of the presence of hypercalciuria, defined as a 
daily urinary calcium excretion > 0.1 mmol/kg bw/day 
(bw = body weight), on a free diet and the common 
composition of the expelled stones (calcium oxalate). 
None of them suffered from primary hyperparathyroid-
ism, overt renal tubular acidosis, or medullary sponge 
kidney disease; no drug known to affect calcium metabo-
lism was consumed by any patient, at least in the two 
months preceding the study. At least 2 months had 
elapsed from the last expelled stone or urological 
intervention. 
For all 64 patients, after 15 days on an ambulatory 
diet, with a moderately restricted calcium content (about 
500 mg), daily urines were collected on two consecutive 
days for the assessment of: calcium, sodium, potassium, 
magnesium, chloride, phosphate, sulphate, citrate, oxa-
late, uric acid, urea, creatinine and the calculation of 
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BMI Sex Activity (no. Stones/ 
(F/M) last 2 years) 
25.0 ± 0.18 14/18 3.1 ± 4.0 
24.6 ± 0.18 15/17 2.8 ± 1.0 
ns ns ns 
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Figure 1. Correlation between IAA values and urinary 
citrate excretion. A significant linear direct correlation 
was evident (Cit = 2.65 + 0.018 x IAA; r = 0.382, 
p < 0.001). 
intestinal alkali absorption (IAA; see below). On the 
third day, after 12 hour of complete fast, freshly voided 
2-hour urines were analysed for: calcium, phosphate, 
hydroxyproline and creatinine. A blood sample was also 
obtained for evaluating: calcium, phosphate and the 
other electrolytes, acid-base balance, creatinine, intact 
PTH, monomeric CT and l,25(OH)2-VitD. Then an 
oral calcium load (OCL) {1 g of calcium ion, given as 
a mixture of calcium gluconate, lactate and carbonate 
(Calcium Sandoz)} was performed and in the urines col-
lected for the following 4 hours, calcium, phosphate, 
hydroxyproline and creatinine were evaluated. A blood 
sample was also obtained 2 hours after OCL for the 
evaluation of: calcium, bicarbonate, PTH and CT. Ac-
cording to fasting calcium excretion values (Ca/Cr above 
or below 0.310 mmol/mmol), the patients were defined 
as respectively fasting hypercalciuric (FH) and not 
fasting hypercalciuric (NFH) SF; by chance, 32 of them 
were FH and 32 NFH. 
In addition, in 18 (9 FH and 9 NFH) of these 
patients, intestinal calcium absorption (ICaA) was 
measured by a double curve analysis, utilizing stable 
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Figure 2. Correlations between the increase of citrate excretion after OCL and both daily urinary citrate (a) and IAA 
(b). A significant positive linear relationship was evident in both cases (daily Cit = 0.037 + 0.033 x dCit; r = 0. 717, 
p < 0.01; IAA = 0.028 + 0.003 x dCit; r = 0.742, p < 0.01). 
strontium as tracer, according to a method already de-
scribed [15): briefly, 2.5 mmol and 1.25 mmol of stable 
strontium were given, on two separate days, respectively 
by mouth and intravenously in bolus; then multiple 
blood samples were obtained at 0, 5, 10, 15, 30, 60, 
120, 180, 240, 360, 480, 600 minutes for the measure-
ment of Sr [ 4] and the calculation of true intestinal ab-
sorption was obtained by integrating the two curves [15]. 
Furthermore, in 10 of these patients, urinary citrate 
and intestinal alkali absorption were evaluated before 
and after OCL, which also represents an alkali load of 
50 mEq. 
Intestinal alkali absorption (IAA) in the daily urine 
of all 64 patients and in urine collected before and after 
OCL, in 10 patients, were calculated according to the 
formula suggested by Oh [17): 
IAA = (Na + K + Ca + Mg) - (Cl + 1.8 iP) 
where Na, K, Ca, Mg, and Cl are expressed as mEq 
and iP (inorganic phosphate) as mmol, excreted in daily 
unnes. 
Tubular threshold of phosphate (TTPi) was calcu-
lated by urinary excretion of phosphate and creatinine in 
fasting urine, according to Walton and Bijvoet [23]. 
Electrolytes, creatinine, urea and uric acid in serum 
and urine were measured by standard methodology 
(autoanalyzer, absorption spectrophotometry, flame 
photometry). 
533 
Strontium in serum was measured by atomic absorp-
tion spectrophotometry [ 4]. 
Urinary oxalate and citrate were measured by col-
umn gaschromatography (Hewlett-Packard 5890 II; 
Supelco SPB-5), in urine collected under 6N HCI. 
Hydroxyproline in urine was determined by liquid 
chromatography (Beckman System Gold), after acid 
hydrolysis. 
PTH was measured by intact-PTH immunoradio-
metric assay (IRMA, NICHOLS Institute Diagnostic, 
San Juan Capistrano, CA, USA), utilizing two different 
policlonal antibodies, purified by affinity chromatogra-
phy, specific for 39-84 and 1-34 regions. The intra-as-
say coefficient of variation was 2.4% and the inter-assay 
coefficient 5. 6 % . 
Calcitonin was analyzed by radio-immunoassay with 
double antibodies in liquid phase (NICHOLS). This as-
say has been proven to be specific for monomeric CT 
(the active hormone) [5], with an intra-assay coefficient 
of variation of 3. 3 % , and an inter-assay coefficient of 
5.5%. 
For l,25(OH)2-vitamin D determination, a 10 ml 
blood sample was collected with heparin, immediately 
centrifuged at 4°C and stored at -20°C, until the assay 
was performed (within 20 days). After acetonitrile ex-
traction, in the presence of tritiated calcitriol (as an indi-
cator of extraction efficiency), plasma sample was sub-
mitted to a "phase switching" procedure, using a single 
C-18OH cartridge (BondElut) for subsequent separation 
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Table 3. Calciotropic hormones, calcium-phosphate parameters, ICaA, and bone resorption levels in FH and NFH 
patients, in basal conditions (mean ± sd). The ICaA values were measured in 18 patients only (see text). 
PTH CT 1,25 OHP/Cr ICaA ITPi iCa 
pg/ml pg/ml pg/ml mmol/mol % mmol/1 mmol/1 
NFH 27.6 ± 10 12.9 ± 12 35.6 ± 11 13.5 ± 4.6 40.1 ± 14 1.0 ± 0.3 1.29 ± 0.02 
n= 32 32 32 32 9 32 32 
FH 20.7 ± 11 28.8 ± 24 38.8 ± 14 18.1 ± 11.1 46.3 ± 8 1.0 ± 0.2 1.31 ± 0.03 
n= 32 32 32 32 9 32 32 
p < 0.01 p < 0.05 ns p < 0.01 ns ns ns 
Table 4. Main results of OCL in FH and NFH patients (mean ± sd). 
dCa/Cr dCa 
mmol/rnmol mmol/1 
NFH (n = 32) 0.185 ± 0.17 0.12 ± 0.10 
FH (n = 32) 0.169 ± 0.27 0.47 ± 0.47 
p ns ns 
of25-(OH)D, 24,25-(OH)2D and 1,25-(OH)2D with iso-
propanolol-hexane; then the final product was dried by 
nitrogen stream and measured by radioreceptorial 
method (RRA, NICHOLS). Each sample was analyzed 
in duplicate. The recovery for this metabolite was 
between 60 and 80 % and each sample was corrected for 
its own recovery. The intra-assay coefficient of 
variation was 10.0% and the inter-assay coefficient of 
variation was 14.0%. 
Statistics were calculated by Anova, paired T test 
and linear regression analysis utilizing a BMDP comput-
er statistical package on an Olivetti M-300-10 PC. 
Results 
The main clinical data of the FH and NFH patients 
are shown in Table 1. No differences were indicated 
between the two groups as regards age. sex distribution, 
renal function (evaluated by creatinine clearance), stone 
activity and body mass index (BMI). 
Table 2 summarizes the main 24-hour urine parame-
ters and the calculated values of IAA in the 2 groups. 
FH patients had significant higher calcium, lower citrate 
urinary values and significant lower IAA levels, with no 
significant difference as regards the other parameters. 
Furthermore, the IAA values were significantly and pos-
itively correlated with citrate urinary excretion (Fig. 1). 
Citrate excretion values did not appear significantly cor-
related with either urea or sulfate daily urinary excre-
tion. 
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dOHP/Cr dPTH dCT 
rnmol/mmol % % 
-4.0 ± 7.7 -44.9 ± 60.4 26.0 ± 45.4 
-4.9 ± 8.5 -34.3 ± 48.9 9.9 ± 34.5 
ns ns ns 
The main clinical data of the 10 patients (6 males, 
4 females; 44.9 ± 8.7 years in age) in whom citrate and 
IAA were measured before and after OCL were as fol-
lows: creatinine clearance 103.7 ± 18.2 ml/min; BMI 
24.8 ± 3.5; and activity (number of stones / last two 
years) = 4.9 ± 5.5. Both urinary citrate and IAA sig-
nificantly increased after OCL (Cit/Cr: 3.91 ± 0.22 
versus 2.37 ± 1.47 rnmol/mmol; p < 0.001; IAA: 2.6 
± 2.2 vs 0.9 ± 1.3 mEq/hr). The increase of citrate 
excretion was significantly and positively related to the 
daily levels of both urinary citrate (Fig. 2a) and IAA 
(Fig. 2b). On the other hand, no correlation was found 
between the increase of IAA after OCL and basal IAA 
values. 
The basal levels of calciotropic hormones and relat-
ed data, ICaA, and BT are shown in Table 3. FH SF 
patients had higher bone resorption (as measured by 
OHP/Cr), with lower PTH and higher CT levels than 
NFH SF. No differences were evident in VitD status, 
ICaA or calcium-phosphate parameters. The concentra-
tions of CT were significantly and directly related to 
daily urinary calcium excretion (Fig. 3a) and inversely 
to citrate excretion (Fig. 3b). Furthermore, the levels of 
CT and hydroxyproline excretion were inversely related 
to IAA basal values (Fig. 4). 
The main results of OCL in the two groups of pa-
tients are shown in Table 4. No significant difference 
was evident between the two groups of patients, however 
CT changes after OCL tended to be higher in NFH, and 
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Figure 3. Correlations between basal CT serum levels and daily urinary excretions of calcium (a) and citrate (b). A 
direct linear correlation was evident between CT and daily calciuria (uCa = 4.9 + 0.022 x CT; r = 0.238, p < 0.05) 
and an indirect hyperbolic correlation with urinary citrate (lnCit = 1.66 - 0.26 x lnCT; r = 0.443, p < 0.001). 
the percentage CT increase was inversely correlated with 
basal levels of CT (Fig. 5). 
Discussion 
An overt lsause of reduced citrate excretion, which 
frequently occurs in the urines of SF patients, is often 
lacking. Considering that both intra and extracellular 
acidosis is the common factor in all the conditions 
known to be accompanied by hypocitraturia [16, 19, 
20), it is conceivable that increased acid or reduced alka-
li intake in the diet might be the causal factor of the "id-
iopathic" form ofhypocitraturia. The method suggested 
by Oh [17] for calculating IAA, by simply measuring 
electrolyte excretion in daily urines, has led to the possi-
bility of testing the above hypothesis. Indeed, the data 
from Pak [18] clearly suggest that IAA affect the levels 
of urinary citrate, and our results confirm these data 
(Fig. 1). However, these results may be a consequence 
of either reduced alkali content in the diet or reduced 
alkali transport efficiency in the intestine. In our pa-
tients, no correlation was found between urinary citrate 
and urea and sulphate daily output (indices of protein 
and acid content of the diet), suggesting that the alkali 
food content is not the main cause in this respect. In-
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deed, Cowley et al. [6], utilizing a citrate load, found 
reduced citrate excretion in stone formers and, more re-
cently, Pak [18) indirectly confirmed these results dem-
onstrating increased IAA after oral citrate load. How-
ever, in the first case [6], the increase in citrate excre-
tion was obtained during the specific load of the same 
alkali (i.e., citrate) and this finding is not necessarily 
indicative of citraturic response after an aspecific alkali 
load, and in the second study [18], the response to alkali 
load was assessed as the increase in IAA, evaluated with 
Oh method, which is not the recommended method to 
measure alkali absorption when an acid-base perturbation 
is going on, as during an alkali load [17]. We tested the 
increase of citrate excretion and of IAA after an alkali 
load of 50 mEq, represented by calcium gluconate, lac-
tate and carbonate, and found that the increase of citrate 
excretion after OCL was direct correlated with basal 
IAA. These finding, in our opinion, support the hypoth-
esis that IAA is mainly dependent on the intestinal trans-
port capacity of the intestine, after an oral alkali load, 
and not on the alkali content of the diet. The lack of 
correlation between basal IAA values and changes in 
IAA after OCL confirm that the measurement of IAA by 
Ob's method during an ongoing perturbation of acid-base 
balance is not reliable, as stressed by Oh himself [ 17]. 
P. Messa et al. 
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Figure 4. Correlations between IAA levels and fasting hydroxyproline urinary excretion (a) and basal CT serum 
concentrations (b). An inverse correlation was evident in both cases (OHP = 21. 7 - 0.07 x IAA; r = 0.345, p < 
0.01; CT = 19.4 - 0.15 x IAA; r = 0.400, p < 0.01). 
Evidence has been provided that fasting hypercalci-
uria is often accompanied by increased bone resorption 
indices and reduced PTH levels [2, 12, 13, 14]. Little 
attention has as yet been paid to the CT role in this 
pathophysiological condition, after a previous finding of 
increased CT levels inhypercalciuria by Ivey et al. [10]. 
Indeed, our data confirm higher values of CT in patients 
with FH, and its values were significantly related to both 
calcium (positively) and citrate (negatively) urinary ex-
cretions (Fig. 3). A possible explanation for all these 
findings may be an increased dietary calcium absorption, 
possibly due to increased VitD bioavailabiiity, which 
might cause increased calcium excretion, stimulated CT 
and suppressed PTH and perhaps by a concomitant in-
creased content of protein and acid load in the diet, re-
duced citrate excretion and increased bone resorption. 
This hypothesis is well supported by Hess's data [8] 
which demonstrated that the relative hypoparathyroidism 
of hypercalciuric stone formers might be explained by 
increased levels of VitD and secondary increased calci-
um absorption. However, in our patients, the levels of 
VitD were completely overlapping in the two groups of 
SF, with or without fasting hypercalciuria. Further-
more, there were no differences in ICaA in the 18 pa-
536 
tients for whom it was measured, nor in the increase of 
calcium excretion after OCL between FH and NFH 
stone formers. The apparent discrepancies between our 
results and Hess's [8] are at least in part due to a dif-
ferent calcium intake in the two studies (reduced in our, 
free in Hess's) and a different method of classification 
(our patients were divided on the basis of the presence 
or otherwise of FH, Hess's patients on the presence or 
otherwise of daily hypercalciuria). An alternative expla-
nation might be that the different alkali absorption by the 
intestine might play a role. 
Indeed, another interesting finding of our study was 
that both citrate and IAA were significantly lower in FH 
patients. Furthermore, IAA values were inversely cor-
related to both hydroxyproline and CT levels. Taken to-
gether all the results might suggest that in FH, reduced 
IAA might induce not only a reduction in citrate excre-
tion, as suggested by Pak [ 18], but also an increased 
bone resorption, secondary to the well known effect of 
acid-base balance perturbations on bone resorptive rate 
[ 11]. The increased bone resorption in tum might sus-
tain increased calcium excretion in fasting urines and a 
resetting of parathyroid glands and thyroid C-cells with 
a consequent compensatory reduced PTH and increased 
Intestinal alkali absorption in stone formers 
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Figure 5. Correlation between the percentage changes 
inCT after OCL and its basal values. An inverse linear 
relationship was evident (dCT% = 29.0 - 0.37 x CT; r 
= 0.277, p < 0.02). 
CT secretion. This resetting of secretion is, at least in 
part, supported by the finding of the reduction of CT se-
cretory response to OCL proportional to the basal CT 
levels: i.e., the higher the basal secretory rate the lower 
the stimulated secretory response. However, to further 
validate this last hypothesis, studies specifically directed 
to measuring the CT secretion rate in these kinds of 
patients are needed. 
Conclusions 
Citrate excretion is mainly controlled by intestinal 
alkali absorptive capacity. Stone formers with fasting 
hypercalciuria, together with higher BT and relative 
hypoparathyroidism, present lower urinary citrate, 
higher urinary calcium and higher CT levels; reduced 
IAA levels might be the link for all these findings. 
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Discussion with Reviewers 
D.M. Wilson: According to the discussion by Oh [17], 
the alteration in IAA could be related to an abnormality 
in GI absorption but could also reflect cellular changes 
or bone buffering. Is it possible that the calculated 
change in IAA is a consequence of altered bone buffer-
ing or cellular metabolism? 
Authors: What you say is true and is affirmed in the 
Discussion. In fact, the method of calculation for alkali 
absorption suggested by Oh [17] is usable only in the 
basal conditions and when it is presumed that there are 
no changes in bone and/or cellular buffering capacity. 
Indeed, our data show that IAA, measured by that meth-
od before and after alkali load (a condition that may be 
accompanied by a change in the cellular buffering) does 
not correlate with the IAA values measured in basal 
conditions. 
H.-G. Tiselius: The authors state that an increased 
IAA, in addition to a reduced excretion of citrate, leads 
to hypercalciuria brought about by an increased bone re-
sorption and an increased calcitonin concentration. The 
patients in this study, however, did not differ in 
1,25-vitamin D levels or in calcium absorption. It 
would be interesting if the authors, in more detail, could 
describe how the different findings in these patients can 
be explained from a reduced IAA. 
Authors: As stated in the text, lower IAA values were 
associated with lower citraturia and higher bone turnover 
indices. The hypothesis suggested is that a lower availa-
bility of alkali from intestine would determine, on one 
hand, lower excretion and/or renal production of citrate, 
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and on the other hand, an increase in bone reabsorption 
due to the well-known direct and indirect effect of acid-
base balance variations on bone metabolism. As regards 
the possible explanation for the increase in CT in condi-
tions of increased bone turnover, it may be only specula-
tively supposed that a condition of increased bone re-
sorption may up-regulate the secretion of a hormone 
(CT) which has the physiological role of "cooling" that 
metabolic process. 
A. Trinchieri: The correlation between the increase of 
citrate excretion after calcium load and both basal uri-
nary citrate and intestinal alkali absorption is impressive, 
but the lack of correlation between the changes in intesti-
nal alkali absorption after calcium load and basal intes-
tinal alkali absorption could be due to the very low num-
ber of patients in which urinary citrate was evaluated. 
Furthermore, it would be interesting to distinguish the 
effect of an alkali load between hypercalciuric and non-
hypercalciuric stone formers. 
Authors: We are in total agreement that, given the rel-
atively low number of observations (10) on IAA before 
and after alkali load, the absence of a correlation may 
not necessarily be true, but we have to comment on our 
statistical data as they stand. 
W.C. de Bruijn: As regards the stone formers (SF), 
please give an indication as to which stones were formed 
( calcium-oxalate, struvite?) and comment on the homo-
geneity of this population in this respect. 
Authors: As stated in the text, all the SF patients 
studied had expelled stones prevalently composed of 
calcium oxalate. 
W.C. de Bruijn: Various tests are performed with 
blood and urine samples from these SF, but can you, 
more explicitly, give the number of patients related to 
each graph. 
Authors: As stated in the text, the total population stud-
ied was 64 patients and basal IAA had been measured in 
all; the 18 patients who had also had their intestinal cal-
cium absorption measured belonged to the first popula-
tion; in 10 of these patients citraturia and IAA were also 
measured both before and after alkali load. Thus, the 
graphs in Figures 1, 3, 4 and 5 show the observations in 
the total population (1 observation per patient); graph In 
Figure 2 shows the observations in the 10 patients who 
had their IAA and citraturia measured before and after 
alkali load. 
W.C. De Bruijn: In most graphs, a linear relation is 
assumed to be present and calculated and the coefficients 
given in the legends. But in Figure 3b suddenly a loga-
rithmic relation is presented. What was the basic as-
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sumption to ask the computer to draw these linear rela-
tions and why not so in Figure 3b, and why is not in all 
cases a non-linear relation is assumed and/or tested. 
Once a (linear) relation is acquired, the correspondence 
coefficient (r) is indicative for the value one can give to 
the observed relation. In most cases shown, this value 
is rather low (ranging from 0.238 - 0. 742) whereas a 
value around unity is acquired for a perfect correspond-
ence. Please comment on this aspect and discuss the 
consequences. 
Authors: The significance of the coefficient "r" is that 
of defining, as is known, the degree of correlation be-
tween two variables, of which one is taken as independ-
ent and the other dependent, the correlation being great-
est for values of "r" close to unity. Of course, when the 
independent variable is the only one (or in any case pre-
ponderant), in order to determine the variations in the 
dependent variable (e.g., time versus a tracer concentra-
tion, the concentration of a chemical substratum versus 
the final product of a chemical reaction, etc.) for a cor-
relation to be "good", the value of "r" must really be 
near unity. In multi factor biological systems (like those 
explored in clinical, physiopathological, epidemiological 
studies, etc.), "r" values are obviously much lower 
(there being many other factors, known and unknown, 
that cannot be considered in every single analysis): 
statistical significance tests intervene precisely to prove, 
or not, whether the relation existing between the varia-
bles examined is significant, weighing it by the number 
of observations and the spread of data around the inter-
polating line. 
As regards the type of interpolation, when two vari-
ables are put in relation to one other, the function (given 
that there is one) that best interpolates the observed 
points should always be sought. It is natural that the 
linear function is the first to be explored but we always 
try the interpolation of at least the most common func-
tions (hyperbolic, parabolic, logarithmic, exponential). 
Of course, in the end, the one that provides the highest 
"r" value will be chosen, to indicate a better interpola-
tion of the way the relation is going. 
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